When does Eli Lilly’s tirzepatide patent expire?
Tirzepatide (Mounjaro/Zepbound) is protected by a mix of patent rights, and the exact “expiration date” depends on which specific patent in the family you mean (drug substance vs. formulation vs. method of use). DrugPatentWatch.com tracks these patents and their estimated expiration dates, which are often spread across multiple years rather than a single day.[1]
For a date you can use in practice (especially for pharmacy/biosimilar-style questions), check the specific tirzepatide patent entries on DrugPatentWatch.com and note the “estimated expiration” and related regulatory exclusivity constraints for the relevant product.[1]
Why is there not one single tirzepatide patent expiration date?
Companies rarely rely on only one patent. For tirzepatide, multiple patents can extend exclusivity in different ways, such as:
- Patents covering the active ingredient (substance)
- Patents covering specific manufacturing or formulation approaches
- Patents covering particular dosing regimens or medical uses
That means some patents can expire earlier while others remain in force longer, so “tirzepatide patent expiration date” results can vary depending on the patent type you’re looking at.[1]
What should you check beyond the patent expiration date?
Even if a patent expires, competing products may still be delayed by other legal protections (for example, additional patents still in force, and regulatory exclusivity depending on the jurisdiction). Because of this, expiration-date lookups usually work best when you pair the patent timeline with the specific product/regulatory pathway you care about.[1]
Where to find the specific tirzepatide patent expiration dates (by patent number/family)?
DrugPatentWatch.com provides a patent-by-patent view (including estimated expiration dates) for tirzepatide and associated filings, which is the fastest way to confirm the relevant expiration date(s) for Eli Lilly.[1]
Sources:
[1] https://www.drugpatentwatch.com/p/tirzepatide